AI-Based Drug Repurposing Method and System

ChangeBridge: EPO Bulletin - AI & Computing (G06N)

Published March 25th, 2026

Detected April 1st, 2026

Summary

The European Patent Office published Wipro Limited's patent application EP4243027A1 for an AI-based drug repurposing method and system. The invention uses artificial intelligence to select candidate drug compounds for therapeutic applications. The designated states cover all EU member states plus associated countries.

View original document View source feed page

What changed

EPO published patent application EP4243027A1 filed by Wipro Limited for a method and system enabling AI-based drug repurposing. The invention relates to using machine learning algorithms to analyze drug compounds and identify candidates suitable for new therapeutic applications. The patent application covers IPC classifications G16C ( cheminformatics) and G06N (machine learning).

Patent publications do not impose compliance obligations on third parties. Pharmaceutical and technology companies developing AI-driven drug discovery tools should review this publication to assess potential overlap with their own IP strategies or development programs. No action is required for regulatory compliance purposes.

Source document (simplified)

← EPO Patent Bulletin

METHOD AND SYSTEM FOR SELECTING CANDIDATE DRUG COMPOUNDS THROUGH ARTIFICIAL INTELLIGENCE (AI)-BASED DRUG REPURPOSING

Publication EP4243027A1 Kind: A1 Mar 25, 2026

Applicants

Wipro Limited

Inventors

MADHUSUDHANAN, Manoj, CHOYARMADATHIL, Sreekumar, VG, Kavinila, MADHUSUDHANAN, Rohan

IPC Classifications

G16C 20/30 20190101AFI20230728BHEP G06N 3/00 20230101ALI20230728BHEP G16C 20/70 20190101ALN20230728BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →